Compounds for the treatment of HIV
US-9944619-B2 · Apr 17, 2018 · US
US10370358B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10370358-B2 |
| Application number | US-201815902883-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 22, 2018 |
| Priority date | Jul 6, 2011 |
| Publication date | Aug 6, 2019 |
| Grant date | Aug 6, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides compounds of formula (I): or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula I and therapeutic methods for treating a Retroviridae viral infection including an infection caused by the HIV virus.
Opening claim text (preview).
What is claimed is: 1. A method for treating an HIV infection in a human, comprising administering a compound of formula I: or a pharmaceutically acceptable salt thereof, to the human, wherein: A is pyridinyl, pyrimidinyl, pyrazinyl or pyridazinyl, wherein any pyridinyl, pyrimidinyl, pyrazinyl, or pyridazinyl of A is substituted with one Z 1 group and optionally substituted with 1, 2, or 3 Z 2 groups; B is absent; or B is —O − and the nitrogen to which the —O − group is attached is N + ; W is —CR 3a R 3b —; R 1 is a bicyclic-heteroaryl, tricyclic-heteroaryl, bicyclic-heterocycle or tricyclic-heterocycle, wherein any bicyclic-heteroaryl, tricyclic-heteroaryl, bicyclic-heterocycle or tricyclic-heterocycle of R 1 is optionally substituted with 1, 2, 3, 4, or 5 Z 3 groups; R 2 is a 6-membered aryl, 5-membered heteroaryl or 6-membered heteroaryl, wherein any 6-membered aryl, 5-membered heteroaryl or 6-membered heteroaryl of R 2 is optionally substituted with 1, 2, or 3 Z 4 groups; each R 3a and R 3b is independently selected from H, (C 1 -C 6 )alkyl, (C 1 -C 3 )haloalkyl, (C 1 -C 6 )heteroalkyl, heterocyclyl(C 1 -C 6 )alkyl-; each Z 1 is independently selected from (C 2 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl, heterocycle and —OR n1 , wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of Z 1 is optionally substituted with 1, 2, 3, 4, or 5 Z 1a or Z 1b groups and wherein any (C 2 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of Z 1 is optionally substituted with 1, 2, 3, 4, or 5 Z 1a groups; each Z 1a is independently selected from (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl, heterocycle, halogen, —CN, —OR n2 , —OC(O)R p2 , —OC(O)NR q2 R r2 , —SR n2 , —S(O)R p2 , —S(O) 2 OH, —S(O) 2 R p2 , —S(O) 2 NR q2 R r2 , —NR q2 R r2 , —NR n2 COR p2 , —NR n2 CO 2 R p2 , —NR n2 CONR q2 R r2 , —NR n2 S(O) 2 R p2 , —NR n2 S(O) 2 OR p2 , —NR p2 S(O) 2 NR q2 R r2 , NO 2 , —C(O)R n2 , —C(O)OR n2 , —C(O)NR q2 R r2 and —S(O) 2 NR n2 COR p2 , wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of Z 1a is optionally substituted with 1, 2, 3, 4, or 5 Z 1c or Z 1d groups; each Z 1b is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl, wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of Z 1b is optionally substituted with 1, 2, 3, 4, or 5 Z 1c groups; each Z 1c is independently selected from (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl, heterocycle, halogen, —CN, —OR n3 , —OC(O)R p3 , C(O)NR q3 R r3 , —SR n3 , —S(O)R p3 , —S(O) 2 OH, —S(O) 2 R p3 , —S(O) 2 NR q3 R r3 , —NR q3 R r3 , —NR n3 COR p3 , —NR n3 CO 2 R p3 , —NR n3 ONR q3 R r3 , —NR n3 S(O) 2 R p3 , —NR n3 S(O) 2 OR p3 , —NR n3 S(O 2 NR q3 R r3 , NO 2 , —C(O)R n3 , —C(O)OR n3 , —C(O)NR q3 R r3 , (C 6 -C 20 )haloaryl, haloheteroaryl, haloheterocycle and (C 1 -C 8 )heteroalkyl; each Z 1d is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl and (C 1 -C 8 )haloalkyl; each R n1 is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl and (C 6 -C 20 )aryl, wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of R n1 is optionally substituted with 1, 2, 3, 4, or 5 Z 1a or Z 1b groups, and wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of R n1 is optionally substituted with 1, 2, 3, 4, or 5 Z 1a groups; each R n2 is independently selected from H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl and (C 6 -C 20 )aryl, wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of R n2 is optionally substituted with 1, 2, 3, 4, or 5 Z 1c or Z 1a groups, and wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of R n2 is optionally substituted with 1, 2, 3, 4, or 5 Z 1c groups; each R p2 is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl and (C 6 -C 20 )aryl, wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of R p2 is optionally substituted with 1, 2, 3, 4, or 5 Z 1c or Z 1a groups, and wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of R p2 is optionally substituted with 1, 2, 3, 4, or 5 Z 1c groups; R q2 and R r2 are each independently selected from H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl and (C 6 -C 20 )aryl, wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of R q2 or R r2 is optionally substituted with 1, 2, 3, 4, or 5 Z 1c or Z 1d groups, and wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of R q2 or R r2 is optionally substituted with 1, 2, 3, 4, or 5 Z 1c groups, or R q2 and R r2 together with the nitrogen to which they are attached form a 5, 6 or 7-membered heterocycle, wherein the 5, 6 or 7-membered heterocycle is optionally substituted with 1, 2, 3, 4 or 5 Z 1c or Z 1d groups; each R n3 is independently selected from H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl, (C 6 -C 20 )aryl, (C 6 -C 20 )haloaryl, haloheteroaryl, haloheterocycle, (C 1 -C 8 )haloalkyl and (C 1 -C 8 )heteroalkyl; each R p3 is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl, (C 6 -C 20 )aryl, (C 6 -C 20 )haloaryl, haloheteroaryl, haloheterocycle, (C 1 -C 8 )haloalkyl and (C 1 -C 8 )heteroalkyl; R q3 and R r3 are each independently selected from H, (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, heterocycle, heteroaryl, (C 6 -C 20 )aryl, haloaryl, haloheteroaryl, haloheterocycle, (C 1 -C 8 )haloalkyl and (C 1 -C 8 )heteroalkyl, or R q3 and R r3 together with the nitrogen to which they are attached form a 5, 6 or 7-membered heterocycle; each Z 2 is independently selected from (C 1 -C 6 )alkyl, (C 1 -C 6 )haloalkyl, (C 3 -C 7 )carbocycle, halogen, CN, OH and —O(C 1 -C 6 )alkyl; each Z 3 is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl, (C 2 -C 8 )alkynyl, (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, halogen, —CN, —OR n4 , —S(O)R p4 , —NR n4 CO 2 R p4 , —NR n4 S(O) 2 R p4 , —C(O)R n4 , —C(O)OR n4 , —C(O)NR q4 R r4 and —B(OR q4 )(OR r4 ) wherein any (C 3 -C 7 )carbocycle and (C 6 -C 20 )aryl of Z 3 is optionally substituted with 1, 2, 3, 4, or 5 Z 3a or Z 3b groups, and wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of Z 3 is optionally substituted with 1, 2, 3, 4, or 5 Z 3a groups; each Z 3a is independently selected from (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl, heterocycle, halogen, —CN, —OR n5 , —OC(O)R p5 , —OC(O)NR q5 R r5 , —SR n5 , —S(O)R p5 , —S(O) 2 OH, —S(O) 2 R p5 , —S(O) 2 NR q5 R r5 , —NR q5 R r5 , —NR n5 COR p5 , —NR n5 CO 2 R p5 , —NR n5 CONR q5 R r5 , —NR n5 S(O) 2 R p5 , —NR n5 S(O) 2 OR p5 , —NR n5 S(O) 2 NR q5 R r5 , NO 2 , —C(O)R n5 , —C(O)OR n5 , and —C(O)NR q5 R r5 , wherein any (C 3 -C 7 )carbocycle, (C 6 -C 20 )aryl, heteroaryl and heterocycle of Z 1a is optionally substituted with 1, 2, 3, 4, or 5 Z 3c or Z 3d groups; each Z 3b is independently selected from (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl, wherein any (C 1 -C 8 )alkyl, (C 2 -C 8 )alkenyl and (C 2 -C 8 )alkynyl of Z 3b is optionally substituted with 1, 2, 3, 4, or 5 Z 3c groups; each Z 3c is independently selected from (C 3 -C 7 )carbocycle, (C 6 -C
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for HIV · CPC title
for RNA viruses · CPC title
Non-condensed quinolines and containing further heterocyclic rings · CPC title
linked by a chain containing hetero atoms as chain links · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.